Susan Halli-Demeter, RN, DNP, CLS reviews the benefits of non-statin, LDL-C-lowering therapies for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD) and severe hypercholesterolemia.
- Identify patients for potential benefit with use of non-statin, LDL-C-lowering therapies.
- Interpret data with non-statin therapies in patients with very high risk ASCVD and severe hypercholesterolemia.
- Review strategies for effective communication strategies in patients with hyperlipidemia to reduce their ASCVD risk.
Susan Halli-Demeter, RN, DNP, CLS